Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-11

Clinical Trial Update: Metformin as an Upstream Therapy in Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 trial investigating metformin as upstream therapy for atrial fibrillation was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: The Guthrie Clinic | Conditions: Atrial Fibrillation | Phase 2 | Status: TERMINATED | Results posted: 2020-06-11